SCHEMBL3412470

SCHEMBL3412470

Bc1ccc2nnc(C(C)c3ccc(N)nn3)n2c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3412111 0.85 MAPK14 (0.33) MAPK14
SCHEMBL253756 0.84 MEN1 (0.36) MAPK14
SCHEMBL3409340 0.84 MAPK14 (0.34) MAPK14
SCHEMBL246806 0.66 PIK3CG (0.40)
SCHEMBL933581 0.62 NOS3 (0.40)
SCHEMBL17229785 0.58 MAPK14 (0.48) MAPK14
SCHEMBL19182951 0.57 MAPK14 (0.40) MAPK14
SCHEMBL23950805 0.57 SCN5A (0.50) MAPK14
SCHEMBL11914746 0.57 MAPK14 (0.58) MAPK14
SCHEMBL20376169 0.57 MAPK14 (0.46) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003338-A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-01-05 WO disclosed